Flagship Ventures Fund V, L.P. 13D and 13G filings for Evelo Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-06-01 5:01 pm Purchase | 2022-05-27 | 13D | Evelo Biosciences, Inc. EVLO | Flagship Ventures Fund V, L.P. | 2,521,366 46.700% | 1,369,863 (+118.96%) | Filing |
| 2021-02-04 5:30 pm Purchase | 2021-02-02 | 13D | Evelo Biosciences, Inc. EVLO | Flagship Ventures Fund V, L.P. | 1,151,503 43.900% | 5,716 (+0.50%) | Filing |
| 2020-07-01 5:04 pm Purchase | 2020-06-29 | 13D | Evelo Biosciences, Inc. EVLO | Flagship Ventures Fund V, L.P. | 1,145,788 49.700% | 234,118 (+25.68%) | Filing |